Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011

Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011–2020

Published:2022-10 Issue:10 Volume:121 Page:2109-2122
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Lao Chong Kei^ORCID,Tseng Mei-Chueh,Chiu Cheng-Hsun,Chen Nan-Yu,Chen Chih-Hung,Chung Wen-Hung,Liu Tsui-Ping,Lu Jang-Jih,Lai Hsin-Chih,Yang Lan-Yan,Lee Chia-Hui,Wu Ting-Shu^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference40 articles.

1. Antibiotic susceptibility testing and species identification of Nocardia isolates: a retrospective analysis of data from a French expert laboratory, 2010-2015;Lebeaux;Clin Microbiol Infect,2019

2. Nocardiosis from 1888 to 2017;Fatahi-Bafghi;Microb Pathog,2018

3. Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis;Hashemi-Shahraki;Sci Rep,2015

4. Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species;Lai;Antimicrob Agents Chemother,2011

5. Nocardiosis: updates and clinical overview;Wilson;Mayo Clin Proc,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple brain abscesses caused by Nocardia farcinica infection after hand injury: A case report and literature review;Medicine;2024-07-19

2. Cervicofacial nocardiosis in an immunocompetent child: A case report and updated review of the literature;Otolaryngology Case Reports;2024-06

3. Primary cutaneous nocardiosis of the ankle caused by N. brasiliensis: a case report;Infection;2024-04-26

4. Primary cutaneous nocardiosis of the ankle caused by N. brasiliensis: a case report;2024-03-22

5. Nocardiosis in an infant with spindle cell rhabdomyosarcoma treated with mild immunosuppressive chemotherapy;Pediatric Blood & Cancer;2024-01-23